Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Unisplendour Chemical is a prominent Chinese chemical manufacturer specializing in the production of hydrocyanic acid and its downstream derivatives. The company is recognized as one of the world's largest producers of glycine, offering pharmaceutical-grade products that serve as essential excipients and intermediates for the global life sciences industry. Beyond glycine, its portfolio includes iminodiacetic acid and various cyanide-based fine chemicals used in the synthesis of agrochemicals and pharmaceuticals. Operating out of a large-scale industrial base in Chongqing, the company leverages advanced synthesis technologies to maintain a leading position in the chemical supply chain. As a key subsidiary of the Unisplendour Group, it provides critical raw materials that support the manufacturing of diverse therapeutic agents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Unisplendour Chemical.